RedHill Biopharma Reports Second Quarter 2019 Financial Results and Operational Highlights


You May Also Like

CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates

-  Companies to Jointly Develop and Commercialize Probody Drug Conjugates Directed Against CD71 -  ...

Keryx Biopharmaceuticals Announces Changes to its Board of Directors

Mark Enyedy appointed to Keryx’s board of directorsCurrent Keryx board member Michael Rogers appointed ...